organic layer was separated and the aqueous layer extracted with EtOAc (20 mL). The combined organic extracts were washed successively with H 2 O and brine, and dried. Removal of solvent under reduced pressure and column chromatography (silica gel, 0-5% EtOAc/hexane) of the residue afforded pure 181. Yield: 0.760 g (71.8%); colourless oil; [ 24 α] D +17.2 (c 1.64, CHCl3 ); IR: 1720 cm -1 ; 1 H NMR: δ 0.74 (t, J = 7.6 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 1.09 (s, 9H), 1.44-1.62 (m, 2H), 1.62-1.88 (m, 3H), 4.23-4.30 (m, 2H), 4.35-4.42 (m, 1H), 5.29-5.45 (m, 2H), 7.33-7.48 (m, 9H), 7.66-7.71 (m, 4H), 8.00-8.05 (m, 2H); 13 C NMR: δ 13.7, 14.2, 19.2, 20.9, 26.8, 31.1, 37.0, 63.2, 72.4, 127.1, 127.3, 128.1, 128.3, 128.9, 129.2, 129.3, 130.3, 132.6, 132.8, 134.1, 135.7, 135.8, 166.4. Anal. Calcd. for C 32 H 40 O 3 Si: C, 76.75; H, 8.05%. Found: C, 76.98; H, 7.86%. (3S,4S)- 3-Methyl-4-O-tert-butyldiphenylsilyl-octan-1,4-diol 183. A mixture of 181 (0.70 g, 1.40 mmol) and 10% Pd-C (0.03 g) in EtOH (10mL) was magnetically stirred under a positive pressure of H 2 gas. After stirring for ~8 h, the mixture was diluted with Et 2 O (15 ml), and the supernatant was passed through a 5 cm pad of silica gel. Removal of 24 solvent under reduced pressure afforded crude 182 in almost quantitative yield. [α] D + 12.6 (c 1.2, CHCl3); colourless oil; IR: 1722 cm -1 ; 1 H NMR: δ 0.71 (t, J = 6.6 Hz, 3H), 1.05 (s merged with d, 12H), 1.10-1.14 (m, 2H), 1.25-1.35 (m, 2H), 1.37-1.40 (m, 1H), 1.79-1.92 (m, 4H), 3.56-3.63 (m, 1H), 4.17-4.31 (m, 2H), 7.32-7.44 (m, 9H), 7.63-7.94 (m, 4H), 7.95-7.98 (m, 2H); 13 C NMR: δ 13.7, 15.2, 19.4, 22.4, 26.9, 27.8, 30.6, 32.3, 34.6, 63.4, 76.8, 127.1, 127.2, 128.1, 129.2, 129.3, 130.2, 132.6, 134.5, 135.8, 166.4. Hydrolysis of 182 (0.60 g, 1.19 mmol) with K 2 CO 3 (0.42 g, 2.98 mmol) in MeOH (5 mL), usual work up and column chromatography (silica gel, 0-10% EtOAc/hexane) 207
24 furnished pure 183. Yield: 0.37 g (78.1%); colourless oil; [α] D + 4.6 (c 1.4, CHCl3 ); IR: 3471 cm -1 ; 1 H NMR: δ 0.76 (t, J = 3.2 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 1.08 (m merged with s, 13H), 1.41-1.46 (m, 4H), 1.50-1.54 (m, 1H), 1.97 (broad s, 1H), 3.50-3.58 (m, 3H), 7.37-7.44 (m, 6H), 7.68-7.73 (m, 4H); 13 C NMR: δ 13.9, 15.5, 19.5, 22.5, 27.1, 28.0, 32.6, 34.3, 34.5, 60.6, 77.4, 127.3, 127.4, 129.4, 129.5, 124.1,134.5, 136.0. Anal. Calcd. for C 25 H 38 O 2 Si: C, 75.32; H, 9.61%. Found: C, 75.11; H, 9.77%. trans-Oak lactone VII: Oxidation of 183 (0.350 g, 0.88 mmol) with PCC (0.218 g, 1.49 mmol) and NaOAc (0.041 mg, 0.50 mmol) in CH 2 Cl 2 (30 mL), and work-up followed by removal of solvent in vacuo yielded crude aldehyde (0.310 g). This was desilylated with Bu 4 NF (1.3 mL, 1.3 mmol, 1 M in THF) in THF (10 mL) at 0 °C. Usual work-up and removal of solvent in vacuo yielded relatively unstable lactol 184 (0.080 g), which on oxidation with PCC (0.185 g, 0.860 mmol) in CH 2 Cl 2 (10 mL), followed by usual work-up and colum chromatography (silica gel, 0-15 % EtOAc/hexane) afforded pure VII. Yield: 24 0.065 g (47.7% overall yield in three steps); colourless oil; [α] D + 93.5 (c 0.25, CHCl 3) [lit. 36e 24 [α] D + 93 (c 0.2, CHCl 3)]; 1 H NMR: δ 0.91 (t, J = 7.2 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H), 1.19-1.65 (m, 6H), 2.16-2.21 (m, 2H), 2.62-2.71 (m. 1H), 3.96-4.02 (m, 1H); 13 C NMR: δ 14.3, 17.2, 22.7, 27.5, 33.8, 36.0, 37.9, 87.6, 176.7. 208
- Page 1:
ASYMMETRIC STRATEGIES FOR THE SYNTH
- Page 6 and 7:
ACKNOWLEDGEMENTS First of all, I wa
- Page 8 and 9:
CONTENTS SYNOPSIS LIST OF FIGURES L
- Page 10:
SYNOPSIS
- Page 13 and 14:
models (e. g. Cram’s model, Felki
- Page 15 and 16:
4 1d 4-(CH 3 ) 2 CH-C 6 H 4 1 : 1.5
- Page 17 and 18:
14. 1n C 6 H 5 CO C 6 H 5 2n 8 77 1
- Page 19 and 20:
imetallic systems. In all the cases
- Page 21 and 22:
For the benzylation reaction, the c
- Page 23 and 24:
O O 3 CHO i O O + OH 13a O O OH O O
- Page 25 and 26:
10 3.5 Ga (2.5) THF KI+LiCl 10 55 5
- Page 27 and 28:
multidrug-resistant (MDR) cancer ce
- Page 29 and 30:
directly afforded the furanose, whi
- Page 31 and 32:
References 1. Stephenson, G. R. Adv
- Page 33 and 34:
LIST OF FIGURES
- Page 35 and 36:
II.3.13 III.1.1 III.1.2 III.1.3 III
- Page 37 and 38:
IV.5.2 IV.5.3 IV.5.4 IV.5.5 1 H NMR
- Page 39 and 40:
Table Title Page No. II.3.1 II.3.2
- Page 41 and 42:
II. .11 PPREAMBLE Demand for specia
- Page 43 and 44:
II. .22 IINTRODUCTIION TO CHIIRALII
- Page 45 and 46:
The most dramatic example in this a
- Page 47 and 48:
H H 2 N OH COOH i PhH 2 CO O H N H
- Page 49 and 50:
Methods of Asymmetric Synthesis: 15
- Page 51 and 52:
O O O O i, ii iii iv HO HO N N OH O
- Page 53 and 54:
Models for Asymmetric Synthesis. 21
- Page 55 and 56:
If a strongly electronegative group
- Page 57 and 58:
enantiomeric products are formed at
- Page 59 and 60:
vi) The balance between chiral auxi
- Page 61 and 62:
IIII. .11 IINTRODUCTIION TO CHIIRAL
- Page 63 and 64:
Scheme II.1.2 However, availability
- Page 65 and 66:
Prof. R. Noyori received the Nobel
- Page 67 and 68:
Apart from the cinchona alkaloids,
- Page 69 and 70:
ligand, it assumes a tetrahedral co
- Page 71 and 72:
Marshall. 53 More recently, Barbero
- Page 73 and 74:
Various protocols have been develop
- Page 75 and 76:
In the absence of a sterically-bulk
- Page 77 and 78:
IIII. .33. . PPRESSENT WORK It is w
- Page 79 and 80:
[pyridinium][Sn 2 Cl 5 ] etc. can b
- Page 81 and 82:
RCHO 59a-j i R OH 60a-j (i) Allyl b
- Page 83 and 84:
Fig. II.3.2. 1 H NMR spectrum of 60
- Page 85 and 86:
in [bmim][BF 4 ] using sub-stoichio
- Page 87 and 88:
The reaction in THF was also follow
- Page 89 and 90:
The integration of the signal at δ
- Page 91 and 92:
The standard reduction potential of
- Page 93 and 94:
It has also been reported, 83a,b th
- Page 95 and 96:
IIII. .33. .33 Gaal lliuum meeddi i
- Page 97 and 98:
5 3.0 5.0 THF LiCl+KI c 14 d 71 6 1
- Page 99 and 100:
3 59d 4-(CH 3 ) 2 CH-C 6 H 4 H 60d
- Page 101 and 102:
Fig. II.3.8. 13 C NMR spectrum of 6
- Page 103 and 104:
Fig. II.3.10. 13 C NMR spectrum of
- Page 105 and 106:
fragmentation peak at m/z 138 (19%)
- Page 107 and 108:
Fig. II.3.13. 13 C NMR spectrum of
- Page 109 and 110:
active catalyst, as suggested for t
- Page 111 and 112:
1-(4-Bromophenyl)-but-3-en-1-ol 59b
- Page 113 and 114:
1H), 7.90-7.93 (m, 1H); 13 C NMR:
- Page 115 and 116:
662, 980, 1079, 1332, 1374 cm -1 .
- Page 117 and 118:
IIIIII. .11 DIIASSTEREOSSELECTIIVE
- Page 119 and 120:
cyclohexylideneglyceraldehyde (1) 3
- Page 121 and 122:
mixture of Zn dust, allyl or γ-sub
- Page 123 and 124:
Fig. III.1.2. 13 C NMR spectrum of
- Page 125 and 126:
Reaction with crotyl bromide: In ca
- Page 127 and 128:
Fig. III.1.5. 1 H NMR spectrum of 6
- Page 129 and 130:
The formation of the 2,3-anti addit
- Page 131 and 132:
To establish the C-4 configuration
- Page 133 and 134:
Allylation with (E) and (Z)-1-bromo
- Page 135 and 136:
(i) Zn, aqueous satd. NH 4 Cl, THF,
- Page 137 and 138:
Fig. III.1.12. 1 H NMR spectrum of
- Page 139 and 140:
Allylation with 1-Bromo-4-(tert)-bu
- Page 141 and 142:
fast and gave a significantly bette
- Page 143 and 144:
espectively) due to the cyclohexyli
- Page 145 and 146:
Fig. III.1.19. 13 C NMR spectrum of
- Page 147 and 148:
was treated with excess amount of b
- Page 149 and 150:
Fig. III.1.20. 1 H NMR spectrum of
- Page 151 and 152:
Fig. III.1.22. 13 C NMR spectrum of
- Page 153 and 154:
stereochemistry of allylation of β
- Page 155 and 156:
of the products were modest (48-62%
- Page 157 and 158:
6 1.2 In (2.0) H 2 O LiCl+ KI 14 72
- Page 159 and 160:
are consistent with our previous re
- Page 161 and 162:
III.3 EXPERIMENTAL SECTION: General
- Page 163 and 164:
(2R,3R)-1,2-Cyclohexylidenedioxy-5-
- Page 165 and 166:
for an additional 2 h, gradually br
- Page 167 and 168:
(m, 2H), 5.82-5.98 (m, 1H), 7.25-7.
- Page 169 and 170:
31.6, 32.2, 63.4, 128.8, 133.0. Ana
- Page 171 and 172:
23 (2R,3S,4R)-1,2-Cyclohexylidenedi
- Page 173 and 174:
(2R,3S,4S)-1,2-Cyclohexylidenedioxy
- Page 175 and 176:
(m, 1H), 3.50-4.02 (m, 5H), 4.10-4.
- Page 177 and 178:
and dried. Removal of solvent in va
- Page 179 and 180:
ine, and dried. Solvent removal und
- Page 181 and 182:
IIV. .11 SSYNTHESSIISS OFF ENANTIIO
- Page 183 and 184:
Scheme IV.1.1 The same group also d
- Page 185 and 186:
IV.1.3: Present work Although sever
- Page 187 and 188:
O O C 6 H 13 i O C 6 H 13 ii OH C 6
- Page 189 and 190:
Fig. IV.1.4. 1 H NMR spectrum of 10
- Page 191 and 192:
the unit-C contribute positively to
- Page 193 and 194:
tartrate, Ti(O-i-Pr) 4 , CH 2 Cl 2
- Page 195 and 196:
Based on this hypothesis, the alcoh
- Page 197 and 198:
OR 3 O R 1 R 2 NaBH 4 H H R 1 R 1 +
- Page 199 and 200: (OH). Oxidative cleavage of its α-
- Page 201 and 202: Fig. IV.2.2. 1 H NMR spectrum of 13
- Page 203 and 204: Fig. IV.2.6. 1 H NMR spectrum of 14
- Page 205 and 206: IIV. .33: : SSYNTHESSIISS OFF 33' '
- Page 207 and 208: For the actual synthesis, (Scheme I
- Page 209 and 210: Fig. IV.3.1. 1 H NMR spectrum of 14
- Page 211 and 212: IV.4: SSYNTHESSIISS OFF 22( (SS) )-
- Page 213 and 214: (i) PhCHO, triethyl orthoformate, M
- Page 215 and 216: O N 3 II Ph HO OH b1 N 3 Ph O O Ben
- Page 217 and 218: Fig. IV.4.2. 1 H NMR spectrum of 91
- Page 219 and 220: Thus, easily accessible 1 has been
- Page 221 and 222: 167 and subsequent reduction gave 1
- Page 223 and 224: from the appearance of 13 C NMR pea
- Page 225 and 226: Fig. IV.5.2. 1 H NMR spectrum of 17
- Page 227 and 228: IV.6 EXPERIMENTAL SECTION (2R,3S,4R
- Page 229 and 230: As described earlier, compound 108
- Page 231 and 232: 19.5, 23.8, 23.9, 25.1, 26.9, 34.6,
- Page 233 and 234: 74.2, 74.4, 110.1, 116.7, 127.6, 12
- Page 235 and 236: mmol) in MeOH (10 mL), work up, fol
- Page 237 and 238: 7.51 (m, 3H), 7.92-8.08 (m, 2H); 13
- Page 239 and 240: subsequent isolation afforded rotam
- Page 241 and 242: 4.18 (t, J = 3.4 Hz, 1H), 4.75-4.84
- Page 243 and 244: -4.21 (c 1.2, CHCl 3 ); IR: 3466, 1
- Page 245 and 246: (3R)- 3,4-O-Cyclohexylidene-2-oxo-1
- Page 247 and 248: Water and EtOAc was added to the mi
- Page 249: 24 179. Yield: 1.49 g (77.5%); colo
- Page 253 and 254: 1. Wender, P. A. Chem. Rev. 1996, 9
- Page 255 and 256: 17. Hanessian, S.; Maji, D. K.; Gov
- Page 257 and 258: 32. For some selective references s
- Page 259 and 260: 43. (a) Cleare, M. J.; Hydes, P. C.
- Page 261 and 262: 54. Barbero, A.; Pulido, F. J.; Rin
- Page 263 and 264: 2008, 1681. (d) Fargeas, V.; Zammat
- Page 265 and 266: 72. Karodia, N.; Guise, S.; Newland
- Page 267 and 268: Kaminski, J.; Millhauser, G.; Ortiz
- Page 269 and 270: Böhm, V. P. W.; Reisinger, C. J. O
- Page 271 and 272: 119. Wender, P. A.; Holt, D. A.; Si
- Page 273 and 274: 140. (a) Chemler, S. R.; Roush, W.
- Page 275 and 276: Lett. 1996, 107, 53. (c) Smith, C.
- Page 277 and 278: 158. Mitsuya, H.; Weinhold, K. J.;
- Page 279 and 280: L.; Zugay, J. A. J. Med. Chem. 1993
- Page 281 and 282: 1. Goswami, D.; Chattopadhyay, A.;